SHANDONG XINHUA(00719),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00719 SHANDONG XINHUA

Closed Labour Day 04-30 16:08:13

6.190

-0.030

-0.48%

High6.220	Low6.170	Vol364.00K
Open6.220	D1 Closing6.220	Amplitude0.80%
Mkt Cap4.31B	Tradable Cap1.21B	Total Shares697.00M
T/O2.25M	T/O Rate0.19%	Tradable Shares195.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"SHANDONG XINHUA","latestPrice":6.19,"timestamp":1777536493002,"preClose":6.22,"halted":0,"volume":364000,"delay":0,"changeRate":-0.004823151125401826,"floatShares":195000000,"shares":697000000,"eps":0.4814718418001191,"marketStatus":"Closed Labour Day","change":-0.03,"latestTime":"04-30 16:08:13","open":6.22,"high":6.22,"low":6.17,"amount":2248920,"amplitude":0.008039,"askPrice":6.19,"askSize":8000,"bidPrice":6.17,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":0.4424370854069385,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":851961600000,"exchange":"SEHK","adjPreClose":6.22,"dividendRate":0.044124,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0.5976226438895347,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"Shandong Xinhua Pharmaceutical Company Limited","latestPrice":14.08,"timestamp":1777532400000,"preClose":14.26,"halted":0,"volume":4746700,"delay":0,"premium":"-61.65"}},"requestUrl":"/m/hq/s/00719/tweets","defaultTab":"tweets","newsList":[{"id":"2631574389","title":"China Oil and Gas swaps assets with Shengli for RMB 1.75 billion stake boost","url":"https://stock-news.laohu8.com/highlight/detail?id=2631574389","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631574389?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:39","pubTimestamp":1777513164,"startTime":"0","endTime":"0","summary":"Shengli Co agreed to acquire four city-gas assets from China Oil and Gas Group units in a share-and-cash deal valued at RMB 1.75 billion.Consideration includes RMB 1.6 billion in newly issued Shengli A-shares priced at RMB 3.06 each, with 521,225,770 shares to be issued.Cash consideration totals RMB 155.9 million, with RMB 100 million earmarked for sellers’ tax liabilities.On completion, China Oil and Gas Group stake in Shengli is set to rise to about 51.11% from about 22.16%, making Shengli a non-wholly owned subsidiary.Closing remains subject to shareholder approvals at both companies, with a circular expected to be sent by May 14, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Oil and Gas Group Limited published the orig","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDLb1QQYM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646235.USD","LU1920063259.USD","LU0188438112.USD","LU0831103253.SGD","BK1221","LU1839390173.USD","SG9999002414.USD","LU1920062954.HKD","SG9999001846.SGD","SG9999004360.SGD","SG9999002406.SGD","LU2242646821.SGD","BK6516","SG9999000343.SGD","SGXZ58947870.SGD","00702","BK6523","SG9999014492.USD","LU0441851309.USD","SG9999006266.SGD","SG9999001135.SGD","LU0192582467.USD","BK6033","LU2401740654.USD","LU2242652126.USD","LU0205439572.USD","SG9999003826.SGD","00719","LU1119993845.HKD","SG9999016042.SGD","LU0532188223.SGD","SG9999013486.USD","LU0898667661.SGD","000756","SG9999013460.SGD","SGXZ27511609.SGD","IE00BKZH1Z71.USD","LU0877626530.USD","LU0326948709.USD","SG9999014484.SGD","SG9999013478.USD","BK1566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630063353","title":"Xinhua Pharmaceutical's Q1 Profit Slides 25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630063353","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630063353?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:24","pubTimestamp":1777375499,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical  recorded a 25% decline in attributable profit in the first quarter of 2026 to 83.9 million yuan from 112.1 million yuan a year prior, according to a Tuesday Hong Kong bourse filing.Earnings per share slipped to 0.12 yuan from 0.15 yuan in the corresponding period of the previous fiscal year.The pharma firm's operating income slipped 0.3% to 2.42 billion yuan from 2.43 billion yuan in the year-ago period.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK1515","BK1191","000756","00719","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113150735","title":"山新华制药2025年营收微增、净利下滑，经营现金流显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1113150735","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113150735?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:50","pubTimestamp":1777369842,"startTime":"0","endTime":"0","summary":"山东方新华制药股份有限公司（SHANDONG...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"山新华制药2025年营收微增、净利下滑，经营现金流显著改善","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148293298","title":"SHANDONG XINHUA Reports Q1 Net Profit of 83.9 Million Yuan, Down 25.15% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1148293298","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148293298?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:47","pubTimestamp":1777369651,"startTime":"0","endTime":"0","summary":"SHANDONG XINHUA (00719) announced its financial results for the first quarter of 2026. The company reported revenue of 2.423 billion yuan, a decrease of 0.28% compared to the same period last year....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181963572","title":"Xinhua Pharmaceutical Publishes 2025 ESG Report: Carbon-Peak Target Set for 2030, R&D Outlays Reach RMB 379.73 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1181963572","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181963572?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:47","pubTimestamp":1777369627,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical (Xinhua Pharmaceutical, 00719) has released its 2025 Environmental, Social and Governance Report covering the period from 1 January to 31 December 2025. The document...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157542460","title":"Shandong Xinhua Initiates Full Electronic Distribution of Corporate Communications, Seeks Shareholders’ Email Details","url":"https://stock-news.laohu8.com/highlight/detail?id=1157542460","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157542460?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:45","pubTimestamp":1777369522,"startTime":"0","endTime":"0","summary":"On 29 April 2026, Shandong Xinhua Pharmaceutical Company Limited issued a reminder to registered shareholders confirming the transition to electronic dissemination of all future corporate...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157609858","title":"Xinhua Pharmaceutical Gains MAH Status for Potassium Chloride Granules, Enters RMB 0.79 Billion Domestic Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1157609858","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157609858?lang=en_us&edition=fundamental","pubTime":"2026-04-24 16:45","pubTimestamp":1777020316,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical Company Limited (“Xinhua Pharmaceutical”) has received a Notification of Approval of Supplementary Drug Application from China’s National Medical Products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173020059","title":"SHANDONG XINHUA Receives Approval Notice for Potassium Chloride Granules Supplemental Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1173020059","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173020059?lang=en_us&edition=fundamental","pubTime":"2026-04-24 16:38","pubTimestamp":1777019923,"startTime":"0","endTime":"0","summary":"SHANDONG XINHUA (00719) announced that Shandong Xinhua Pharmaceutical Co., Ltd. recently received a Drug Supplement Application Approval Notice for Potassium Chloride Granules from the National...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113433094","title":"CATL Shareholder Sets A-Share Transfer Price at 410.34 Yuan; Nitrogen Fertilizer Prices May Climb Further","url":"https://stock-news.laohu8.com/highlight/detail?id=1113433094","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113433094?lang=en_us&edition=fundamental","pubTime":"2026-04-21 07:40","pubTimestamp":1776728442,"startTime":"0","endTime":"0","summary":"Global nitrogen fertilizer exporter Fertiglobe indicated that nitrogen fertilizer prices have surged to nearly double pre-Iran conflict levels and could rise further as key supplies remain blocked in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02607","SG9999001689.USD","SHPMY","LU0143863198.USD","BK0224","LU1934453819.USD","300476","LU0531970944.HKD","LU0724618433.USD","SG9999002828.SGD","LU0593848301.USD","LU0124384867.USD","LU1152091754.HKD","LU2041044095.USD","LU2298321311.HKD","LU2506951792.HKD","301200","LU2238339852.HKD","SG9999014674.SGD","LU0048580855.USD","BK1116","LU0359201885.HKD","LU2153592121.USD","02476","LU0254981946.USD","LU1868838027.USD","LU1997245094.SGD","03983","LU2097828474.EUR","IE00BPRC5H50.USD","BK4519","LU0823426308.USD","LU0823437842.USD","LU2506952337.HKD","LU0611395673.USD","LU2275660780.HKD","LU0348805143.USD","LU2360108059.USD","LU0502904849.HKD","03750","LU1960683339.HKD","LU2097828557.USD","LU1008478684.HKD","000756","IE00B8HQ1Z84.USD","LU0315179316.USD","LU0607220059.USD","LU0320764755.SGD","LU1051768304.USD","LU1102505929.USD","SNFRY","LU0106959298.USD","LU1861214812.USD","LU0312595415.SGD","BK1129","LU0828237940.HKD","LU2424517915.HKD","LU0140636845.USD","600941","LU0516423091.SGD","EVS.SI","LU0210526637.USD","LU1978683503.SGD","LU0188438112.USD","LU0828238088.HKD","LU1720050803.USD","COIN","LU2449936058.SGD","CBLUY","LU3063872942.SGD","LU1880383366.USD","09696","02575","LU2357125470.USD","SG9999004220.SGD","002466","LU2495084118.USD","00451","BK4141","LU0143863784.USD","LU1064130708.USD","LU2148510915.USD","IE0032431581.USD","LU0269904917.USD","LU0651947912.USD","BK4526","META","LU0531971595.HKD","LU0043850808.USD","LU0244354667.USD","LU1226287529.USD","LU0650527681.SGD","SG9999001846.SGD","LU2580892862.HKD","LU0181495838.USD","IE0008368742.USD","LU0054450605.USD","LU0048575426.USD","SG9999001903.USD","LU2097828631.EUR","LU1242518857.USD","LU0107464264.USD","SG9999003461.SGD","LU0072913022.USD","LU0106259558.USD","HK0000181112.HKD","IE0003795394.USD","IE00BZ08YT58.USD","LU2506952253.HKD","PLUG","LU1993786604.SGD","IE00B543WZ88.USD","LU2039709279.SGD","IE0003851619.USD","INTC","LU0572944931.SGD","LU1226287792.SGD","LU1813983027.USD","LU2360107325.USD","LU0405327494.USD","LU1794554557.SGD","LU0328353924.USD","LU1820825898.SGD","LU1880383440.USD","LU2242644610.SGD","LU1242518931.SGD","LU2476274308.USD","LU2476274720.SGD","00719","IE0008369823.USD","IE00B031HY20.USD","LU0132412106.USD","LU0516422366.SGD","LU0594300179.USD","LU0449515922.USD","LU0823414478.USD","LU1048596156.SGD","BK1594","LU1770034418.SGD","LU2289578879.USD","LU2506952410.USD","LU2125910500.SGD","LU0605514214.HKD","04335","LU0501845795.SGD","LU0359202008.SGD","LU0516423174.USD","LU1023057109.AUD","03393","BK4585","LU1580142542.USD","LU2097828714.EUR","LU0594300419.USD","IE00BZ199S13.USD","BK1610","LU0823426480.USD","LU1048588211.SGD","BK1154","LU0235996351.USD","TSLA","LU0516422440.USD","SG9999002463.SGD","LU0106252389.USD","LU2298322129.HKD","IE00BZ08YR35.GBP","LU0251143458.SGD","LU2580892789.USD","LU0821914370.USD","SG9999000327.SGD","01093","LU1146622755.USD","LU2298064838.USD","IE00B5MMRT66.SGD","LU0370786039.SGD","LU0455707207.USD","LU1951186391.HKD","LU0192582467.USD","LU2328871848.SGD","IE00BZ08YS42.EUR","601607","LU0326948709.USD","LU0359201612.USD","LU0516422952.EUR","LU1039395188.USD","LU0828237510.HKD","LU1226287875.USD","LU1769817096.USD","LU0029875118.USD","LU0231483743.USD","LU1769817179.HKD","LU0405327148.USD","LU1997244956.HKD","IE00B8L5B284.USD","LU1655091616.SGD","BK1521","BK1554","LU0259732245.USD","LU2153591404.USD","LU1188198961.HKD","LU0164872284.USD","LU0543330483.HKD","02691","LU0011963245.USD","LU1997245177.USD","LU1719994722.HKD","BK1147","LU0463099449.HKD","LU0302445910.USD","LU0314109678.HKD","LU2348774022.SGD","LU0979878070.USD","LU1226288253.USD","LU0327786744.USD","LU1064131003.USD","00941","LU0228659784.USD","SGXZ49509284.SGD","LU0880133367.SGD","LU1102505762.USD","LU0456827905.SGD","BK1191","LU0165289439.USD","LU0505663152.USD","BK1515","LU0449509016.USD","LU1939255532.USD","LU0326950275.SGD","603093","LU2097828805.USD","LU1969619763.USD","LU2249611893.SGD","LU1226288170.HKD","LU0047713382.USD","BK4588","03200","LU0509642566.USD","LU1255011170.USD","LU1721428347.USD","LU2294711713.HKD","LU0072462343.USD","LU0823414551.USD","LU2152927971.USD","LU2778985437.USD","LU1303224171.USD","LU1861219969.SGD","LU0672654166.SGD","LU1328277881.USD","LU0164865239.USD","LU1515016050.SGD","LU0128522157.USD","LU2125910849.SGD","IE00BD6J9T35.USD","300750","SGXZ81163826.USD","LU1868837565.USD","06608","LU2399975544.HKD","LU1979443071.USD","LU0049853897.USD","LU1831875114.USD","LU2294711473.HKD","01866","LU0048388663.USD","00297","LU0469268626.HKD","LU1807302812.USD","IE00B29SXG58.USD","LU0051755006.USD","LU2045819591.USD","LU2394011477.USD","LU0651946864.USD","SG9999000459.SGD","LU0067412154.USD","LU2092937221.SGD","LU0149534421.HKD","LU1051769294.HKD","LU0214875030.USD","LU0261950470.USD","LU0871576103.HKD","LU2348773727.SGD","LU2477742899.HKD","LU1251922891.USD","LU0039217434.USD","LU1781817850.SGD","LU1152091168.USD","IE00B3M56506.USD","LU1961090484.USD","LU1808992512.USD","HK0000165453.HKD","HK0000181138.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167726310","title":"Shandong Xinhua to Convene 28 April 2026 Board Meeting for Q1 Results Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1167726310","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167726310?lang=en_us&edition=fundamental","pubTime":"2026-04-15 16:44","pubTimestamp":1776242676,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical Company Limited announced that its board of directors will meet at 9:30 a.m. on Tuesday, 28 April 2026, in the company’s conference room at No. 1 Lutai Avenue, Hi-tech...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198016437","title":"SHANDONG XINHUA Receives Drug Registration Certificate for Bumetanide Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1198016437","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198016437?lang=en_us&edition=fundamental","pubTime":"2026-04-15 16:37","pubTimestamp":1776242259,"startTime":"0","endTime":"0","summary":"SHANDONG XINHUA (00719) has announced that it recently obtained the Drug Registration Certificate for Bumetanide Injection from the National Medical Products Administration. In April 2026, the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115480682","title":"SHANDONG XINHUA (00719) Secures Drug Registration Certificate for Concentrated Sodium Potassium Magnesium Calcium Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1115480682","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115480682?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:20","pubTimestamp":1775560839,"startTime":"0","endTime":"0","summary":"SHANDONG XINHUA Pharmaceutical Co., Ltd. (00719) has announced that it recently received the Drug Registration Certificate for Concentrated Sodium Potassium Magnesium Calcium Injection from the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","00719","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112530442","title":"Xinhua Pharmaceutical Gains NMPA Approval for Multi-Electrolyte Injection, Broadening Formulation Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1112530442","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112530442?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:06","pubTimestamp":1775559965,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical Company Limited (“Xinhua Pharmaceutical”) announced that it has secured a Drug Registration Certificate (National Medicine Zhunzi H20263780) from China’s National...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625262941","title":"Investors Can Find Comfort In Shandong Xinhua Pharmaceutical's (HKG:719) Earnings Quality","url":"https://stock-news.laohu8.com/highlight/detail?id=2625262941","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625262941?lang=en_us&edition=fundamental","pubTime":"2026-04-06 08:02","pubTimestamp":1775433727,"startTime":"0","endTime":"0","summary":"The most recent earnings report from Shandong Xinhua Pharmaceutical Company Limited ( HKG:719 ) was disappointing for...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-719/shandong-xinhua-pharmaceutical-shares/news/investors-can-find-comfort-in-shandong-xinhua-pharmaceutical","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-719/shandong-xinhua-pharmaceutical-shares/news/investors-can-find-comfort-in-shandong-xinhua-pharmaceutical","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00719","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163130541","title":"Optical Chip Unicorn Xizhi Technology Files for Hong Kong IPO Amid Market Frenzy and Financial Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=1163130541","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163130541?lang=en_us&edition=fundamental","pubTime":"2026-04-02 16:15","pubTimestamp":1775117756,"startTime":"0","endTime":"0","summary":"The rapid advancement of AI large-scale models has reshaped the development logic of numerous industries. Optical chips represent one of the most prominent examples. Recently, NVIDIA made substantial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719","TCEHY","000756","LITE","BK4588","BK4585","00700","09888","BK4535","NVDA","BIDU","COHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166898750","title":"SHANDONG XINHUA secures NMPA approval to take over MAH for Galculus Bovis & Metronidazole Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=1166898750","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166898750?lang=en_us&edition=fundamental","pubTime":"2026-04-01 16:52","pubTimestamp":1775033537,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical Company Limited (SHANDONG XINHUA) announced that it has received the National Medical Products Administration’s Notification of Approval of Supplementary Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128747953","title":"SHANDONG XINHUA (00719) Receives Approval Notice for Artificial Calculus Bovis and Metronidazole Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=1128747953","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128747953?lang=en_us&edition=fundamental","pubTime":"2026-04-01 16:40","pubTimestamp":1775032824,"startTime":"0","endTime":"0","summary":"SHANDONG XINHUA (00719) announced that it has recently received the Drug Supplement Application Approval Notice for Artificial Calculus Bovis and Metronidazole Capsules from the National Medical...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105666107","title":"Board Reshuffle at SHANDONG XINHUA as Non-Executive Director Retires","url":"https://stock-news.laohu8.com/highlight/detail?id=1105666107","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105666107?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:54","pubTimestamp":1774947254,"startTime":"0","endTime":"0","summary":"SHANDONG XINHUA (00719) has announced that Mr. Xu Lie has resigned from his position as a non-executive director and as a member of the Board's Development Strategy Committee, having reached the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133003254","title":"Shandong Xinhua Pharmaceutical: Non-Executive Director Xu Lie Steps Down Upon Retirement","url":"https://stock-news.laohu8.com/highlight/detail?id=1133003254","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133003254?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:44","pubTimestamp":1774946672,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical Company Limited announced that Non-Executive Director Xu Lie has resigned from the Board and the Strategic Development Committee effective 31 March 2026, citing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180867907","title":"Shandong Xinhua Pharmaceutical Reports Annual Results with 38.32% Drop in Net Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1180867907","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180867907?lang=en_us&edition=fundamental","pubTime":"2026-03-27 16:52","pubTimestamp":1774601558,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical (00719) announced its annual results for the period ended December 31, 2025. The company reported revenue of 87.55 billion yuan, an increase of 3.41% year-on-year. Net...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xhzy.com","stockEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0283},{"period":"3month","weight":-0.1182},{"period":"6month","weight":-0.1094},{"period":"1year","weight":0.177},{"period":"ytd","weight":-0.0607}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shandong Xinhua Pharmaceutical Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of chemical raw materials, pharmaceutical preparations and chemical products. The Company operates three segments. The Chemical Raw Materials segment is mainly engaged in the development, manufacturing and sales of raw materials for antipyretics and analgesics such as caffeine series, ibuprofen series, aspirin series, dopamine series, barbiturates and pipemidic acid. The Pharmaceutical Preparations segment is mainly engaged in the development, manufacturing and sales of tablets, injections and capsules such as pipemidic acid tablets, aminopyrine and nimodipine tablets. The Pharmaceutical Intermediates and Other Products segment is mainly engaged in the development, manufacturing and sales of pharmaceutical intermediates and other products. The Company mainly operates its business in the domestic market and overseas markets such as the Americas and Europe.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.012276},{"month":2,"riseRate":0.766667,"avgChangeRate":0.099858},{"month":3,"riseRate":0.433333,"avgChangeRate":-0.00788},{"month":4,"riseRate":0.7,"avgChangeRate":0.100968},{"month":5,"riseRate":0.344828,"avgChangeRate":0},{"month":6,"riseRate":0.448276,"avgChangeRate":-0.003358},{"month":7,"riseRate":0.586207,"avgChangeRate":0.015918},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.041915},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.018334},{"month":10,"riseRate":0.448276,"avgChangeRate":0.008832},{"month":11,"riseRate":0.551724,"avgChangeRate":0.012328},{"month":12,"riseRate":0.586207,"avgChangeRate":0.023867}],"exchange":"SEHK","name":"SHANDONG XINHUA","nameEN":"SHANDONG XINHUA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SHANDONG XINHUA(00719),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SHANDONG XINHUA(00719) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SHANDONG XINHUA,00719,SHANDONG XINHUA股票,SHANDONG XINHUA股票老虎,SHANDONG XINHUA股票老虎国际,SHANDONG XINHUA行情,SHANDONG XINHUA股票行情,SHANDONG XINHUA股价,SHANDONG XINHUA股市,SHANDONG XINHUA股票价格,SHANDONG XINHUA股票交易,SHANDONG XINHUA股票购买,SHANDONG XINHUA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SHANDONG XINHUA(00719),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SHANDONG XINHUA(00719) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}